By taking part in a weight loss clinical trial, eligible individuals may access treatments designed to address obesity-related conditions under close medical supervision
per os/by mouth [PO]) effectively reduced the 5-HT 1B receptor agonist-induced OCD-related behaviour of male mice as measured by the open field test and delayed alternation task, which may further support the drugs effectiveness in treating OCD
Retatrutide combines GLP-1, GIP, and glucagon agonism for triple-pathway engagement, while Liraglutide targets GLP-1 alone
This small proof of concept study involved just 114 patients, which is too small to draw any statistical conclusions
Frias JP, Bastyr EJ Cell Metab
Please note: The following 7-day meal plan is based on a total of 1,400-1,600 calories per day